Global Biotechnology Market Report and Forecast 2024-2032
Description
Global Biotechnology Market Report and Forecast 2024-2032
Global Biotechnology Market Report and Forecast 2024-2032
Global Biotechnology Market Outlook
The global biotechnology market size was valued at USD 1292.5 billion in 2023, driven by increase in research activities on disease treatment across the globe. The market size is anticipated to grow at a CAGR of 19% during the forecast period of 2024-2032 to achieve a value of USD 6189.9 billion by 2032.
Biotechnology: Introduction
Biotechnology is a dynamic field that merges biology with technology, harnessing cellular and biomolecular processes to develop technologies and products that improve lives and the health of our planet. This interdisciplinary field spans various applications, including medical innovations like gene therapy and vaccines, agricultural enhancements like drought-resistant crops, and environmental solutions like biodegradable plastics. Biotechnology is pivotal in advancing medical treatments, enhancing food sustainability, and addressing environmental challenges, driving a new era of scientific and industrial progress.
Key Trends in the Global Biotechnology Market
Advances in genomics are fueling personalized medicine, allowing treatments to be tailored to individuals' genetic makeup, improving efficacy and reducing side effects. Technologies like CRISPR are revolutionizing genetic engineering, with applications in disease treatment, agriculture, and biofuels.
There's a surge in the development of biopharmaceuticals, including vaccines, antibodies, and gene therapies, offering solutions for previously untreatable conditions. With many biologics' patents expiring, there's a growing market for biosimilars, offering cost-effective alternatives to expensive biologics.
Advancements in stem cell research are promising for regenerating damaged tissues and organs, potentially revolutionizing treatments for a variety of conditions. This involves creating functional tissues to replace or repair damaged ones, with applications in medical implants and organ transplantations.
Enhancements in crop yield, durability, and nutritional content are being achieved through genetic modifications, addressing food security issues. There's a trend towards using biological agents for pest control, reducing the reliance on chemical pesticides and their environmental impact.
The integration of big data analytics is speeding up drug discovery and development processes, making them more cost-effective and efficient. AI algorithms are being used to predict how different drugs will work, significantly cutting down the time and cost of drug development. 3D bioprinting is also being used to print tissues and organs, with potential applications in regenerative medicine and drug testing.
Global Biotechnology Market Segmentation
Market Breakup by Product Type
- Instruments
- Reagents and Services
- Software
- Nano Biotechnology
- PCR Technology
- DNA Sequencing
- Chromatography
- Tissue Engineering and Regeneration
- Cell Based Assays
- Fermentation
- Others
- Bio-pharmacy
- Bio-industrial
- Bio-services
- Bioinformatics
- Bio-agriculture
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
- Others
- Direct Tender
- Third Party Distributors
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America region often leads in biotechnology due to strong investment in R&D, a robust regulatory framework, and significant governmental and private funding. The region is known for its innovation in biopharmaceuticals, genomics, and personalized medicine.
Europe shows strong growth, backed by substantial investments in healthcare, a favorable regulatory environment, and a focus on research. Countries like Germany, the UK, and France are significant contributors, particularly in areas like biopharmaceuticals and agricultural biotech.
Asia-Pacific is experiencing rapid growth, driven by increasing healthcare expenditure, rising demand for biotech solutions in agriculture, and growing government initiatives in biotech research. Countries like China, Japan, and South Korea are heavily investing in biotechnology R&D.
Latin America is an emerging market with growing potential, driven by increasing investment in healthcare infrastructure, rising awareness of biotech products, and supportive government policies, particularly in countries like Brazil and Mexico.
Middle East & Africa shows gradual growth with increasing investment in healthcare, growing awareness about the benefits of biotechnology, and government initiatives to promote research and development in the region.
Global Biotechnology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- Agilent Technologies Inc.
- Danaher
- BD
- Bio-Rad Laboratories Inc.
- General Electric
- bioMérieux SA
- LONZA
- F. Hoffmann-La Roche Ltd.
- Hoefer, Inc.
- PerkinElmer Inc.
- Merck KGaA
- Promega Corporation
- Quality Biological
- Siemens
- Bio-Techne
- TAKARA HOLDINGS INC.
- Sysmex Corporation
- Tosoh Corporation
- Olympus Corporation
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Biotechnology Market Overview
- 3.1 Global Biotechnology Market Historical Value (2017-2023)
- 3.2 Global Biotechnology Market Forecast Value (2024-2032)
- 4 Global Biotechnology Market Landscape
- 4.1 Global Biotechnology Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Biotechnology Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Biotechnology Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Biotechnology Market Segmentation
- 6.1 Global Biotechnology Market by Product Type
- 6.1.1 Market Overview
- 6.1.2 Instruments
- 6.1.3 Reagents and Services
- 6.1.4 Software
- 6.2 Global Biotechnology Market by Technology
- 6.2.1 Market Overview
- 6.2.2 Nano Biotechnology
- 6.2.3 PCR Technology
- 6.2.4 DNA Sequencing
- 6.2.5 Chromatography
- 6.2.6 Tissue Engineering and Regeneration
- 6.2.7 Cell Based Assays
- 6.2.8 Fermentation
- 6.2.9 Others
- 6.3 Global Biotechnology Market by Application
- 6.3.1 Market Overview
- 6.3.2 Bio-pharmacy
- 6.3.3 Bio-industrial
- 6.3.4 Bio-services
- 6.3.5 Bioinformatics
- 6.3.6 Bio-agriculture
- 6.4 Global Biotechnology Market by End User
- 6.4.1 Market Overview
- 6.4.2 Pharmaceutical and Biotechnology Companies
- 6.4.3 Contract Research Organizations
- 6.4.4 Academic and Research Institutes
- 6.4.5 Others
- 6.5 Global Biotechnology Market by Distribution Channel
- 6.5.1 Market Overview
- 6.5.2 Direct Tender
- 6.5.3 Third Party Distributors
- 6.5.4 Others
- 6.6 Global Biotechnology Market by Region
- 6.6.1 Market Overview
- 6.6.2 North America
- 6.6.3 Europe
- 6.6.4 Asia Pacific
- 6.6.5 Latin America
- 6.6.6 Middle East and Africa
- 7 North America Biotechnology Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Biotechnology Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Biotechnology Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Biotechnology Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Biotechnology Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Abbott
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisition
- 17.1.5 Certifications
- 17.2 Agilent Technologies Inc.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisition
- 17.2.5 Certifications
- 17.3 Danaher
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisition
- 17.3.5 Certifications
- 17.4 BD
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisition
- 17.4.5 Certifications
- 17.5 Bio-Rad Laboratories Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisition
- 17.5.5 Certifications
- 17.6 General Electric
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisition
- 17.6.5 Certifications
- 17.7 bioMérieux SA
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisition
- 17.7.5 Certifications
- 17.8 LONZA
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisition
- 17.8.5 Certifications
- 17.9 F. Hoffmann-La Roche Ltd.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisition
- 17.9.5 Certifications
- 17.10 Hoefer, Inc.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisition
- 17.10.5 Certifications
- 17.11 PerkinElmer Inc.
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisition
- 17.11.5 Certifications
- 17.12 Merck KGaA
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisition
- 17.12.5 Certifications
- 17.13 Promega Corporation
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisition
- 17.13.5 Certifications
- 17.14 Quality Biological
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisition
- 17.14.5 Certifications
- 17.15 Siemens
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisition
- 17.15.5 Certifications
- 17.16 Bio-Techne
- 17.16.1 Financial Analysis
- 17.16.2 Product Portfolio
- 17.16.3 Demographic Reach and Achievements
- 17.16.4 Mergers and Acquisition
- 17.16.5 Certifications
- 17.17 TAKARA HOLDINGS INC.
- 17.17.1 Financial Analysis
- 17.17.2 Product Portfolio
- 17.17.3 Demographic Reach and Achievements
- 17.17.4 Mergers and Acquisition
- 17.17.5 Certifications
- 17.18 Sysmex Corporation
- 17.18.1 Financial Analysis
- 17.18.2 Product Portfolio
- 17.18.3 Demographic Reach and Achievements
- 17.18.4 Mergers and Acquisition
- 17.18.5 Certifications
- 17.19 Tosoh Corporation
- 17.19.1 Financial Analysis
- 17.19.2 Product Portfolio
- 17.19.3 Demographic Reach and Achievements
- 17.19.4 Mergers and Acquisition
- 17.19.5 Certifications
- 17.20 Olympus Corporation
- 17.20.1 Financial Analysis
- 17.20.2 Product Portfolio
- 17.20.3 Demographic Reach and Achievements
- 17.20.4 Mergers and Acquisition
- 17.20.5 Certifications
- 18 Global Biotechnology Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



